Study: NCT00948506

Adverse event: Gastrointestinal haemorrhage
Serious: yes
Organ System: Gastrointestinal disorders
Notes: Participant self-reported an episode of gastrointestinal bleeding resulting in hospitalization but no documentation of the hospitalization was received. The IRB was notified.
Frequency: 1 affected / 11 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 3 affected / 11 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 2 affected / 11 at risk

Adverse event: Erythema of the treatment area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Erythema - in 1 subject on the 3% cidofovir-treated side; in 2 subjects on the 1% cidofovir-treated side
Frequency: 2 affected / 11 at risk

Adverse event: Pruritis of treatment area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Pruritis - in 1 subject on the 3% cidofovir-treated side; in 1 subject on both the 1% cidofovir-treated and placebo-treated sides
Frequency: 1 affected / 11 at risk

Adverse event: Oral herpes
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 11 at risk

Adverse event: Toothache after a dental procedures
Serious: no
Organ System: Surgical and medical procedures
Frequency: 1 affected / 11 at risk

Adverse event: Neck swelling after surgical nerve block
Serious: no
Organ System: Surgical and medical procedures
Frequency: 1 affected / 11 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 9 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 9 at risk

Adverse event: Erythema of the treatment area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Erythema - in 1 subject on the 3% cidofovir-treated side; in 2 subjects on the 1% cidofovir-treated side
Frequency: 1 affected / 9 at risk

Adverse event: Pruritis of treatment area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Notes: Pruritis - in 1 subject on the 3% cidofovir-treated side; in 1 subject on both the 1% cidofovir-treated and placebo-treated sides
Frequency: 1 affected / 9 at risk

Adverse event: Oral herpes
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 9 at risk

Adverse event: Rash over the untreated area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 9 at risk

Adverse event: Skin tenderness of untreated area
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 9 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 9 at risk

Adverse event: Cough
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 9 at risk

Adverse event: Eyelid twitch
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 9 at risk

Adverse event: Flare of pre-existing brachial neuritis
Serious: no
Organ System: Nervous system disorders
Frequency: 1 affected / 9 at risk

Adverse event: Animal bite
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 9 at risk